Trump Tweets: Everybody Takes a Beating Sometime

The reality of a President Trump in this day and age means that stocks and sectors will, undoubtedly, be sensitive to his tweets. We have already seen this sensitivity on full display even before he officially takes office on Friday. 

With this in mind, the pricing power of some biotech and healthcare firms is likely in focus as the healthcare issues are discussed, debated, potentially repealed and replaced. 

IBB, the large cap biotech sector ETF, has given up about half of its gains so far in 2017. With the prospect of some Trump Tweets aimed specifically at healthcare and large cap bios, I am easing off the idea flow for them as imminent longs, especially with the broad market operating in a choppy range. 

Biotech/healthcare traders and firms ought not to take this personally, as I suspect throughout the next few years, every sector will take a beating sometime. 

More in my recap after the bell.